GRAL Stock Analysis: Buy, Sell, or Hold?
GRAL - GRAIL, Inc. Common Stock
$97.82
-3.16 (-3.13%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 19, 2026
18d
Get Alerted When GRAL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called GRAL this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GRAL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GRAL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GRAL is currently trading at $97.82, which is considered fair relative to its 30-day fair value range of $90.97 to $106.18.
Technical Outlook: Technically, GRAL is in a strong uptrend. Immediate support is located at $93.00, while resistance sits at $118.84. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $115.00 (+13.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GRAL is in a strong uptrend. Immediate support is located at $93.00, while resistance sits at $118.84. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $115.00 (+13.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$90.97 -
$106.18
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
Protect Your Profits
Holding GRAL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading below Wall St target ($115.00)
- CAUTION: Recommendation downgraded due to -6.7% 5-day decline
Fair Price Analysis
30-Day Fair Range
$90.97 -
$106.18
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$93.00
Resistance Level
$118.84
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-9.33
Wall Street Target
$115.00
(+13.9%)
Revenue Growth (YoY)
26.3%
Profit Margin
-286.4%
Last updated: January 30, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM
Data refreshes hourly during market hours. Next update: 12:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRAL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua J Ofman
SELL
6114 shares
2025-10-16
Joshua J Ofman
SELL
8865 shares
2025-10-15
Robert P Ragusa
SELL
7239 shares
2025-10-15
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced GRAL Option Strategies
Professional options setups generated by AI based on today's GRAL price and gamma walls.
